scythian500
SENIOR MEMBER
- Joined
- Nov 16, 2014
- Messages
- 2,211
- Reaction score
- 1
- Country
- Location
ArioGen Company is producing Factor 7 Strategic Medicine... Denmark was the only country with the technology to produce Factor 7 medicine and now Iran is the second one...
Factor VII (rFVIIa) is only indicated for use in hemophilia A and B patients who have developed inhibitor antibodies to factor VIII (antihemophilic factor) or factor IX{01}.
Hemophilia A, hemorrhagic complications of (treatment)—Factor VIIa is indicated for the control of bleeding events in hemophilia A and B patients with inhibitor antibodies to factor VIII or factor IX{01}.
The medicine is provided to Iranian patients free of charge and also exported to countries like Russia, Turkey and EU
داروی استراتژیک فاکتور ۷ آماده ورود به بازار جهانی - مشرق نیوز | آخرین اخبار ایران و جهان | mashreghnews.ir
Factor VII (rFVIIa) is only indicated for use in hemophilia A and B patients who have developed inhibitor antibodies to factor VIII (antihemophilic factor) or factor IX{01}.
Hemophilia A, hemorrhagic complications of (treatment)—Factor VIIa is indicated for the control of bleeding events in hemophilia A and B patients with inhibitor antibodies to factor VIII or factor IX{01}.
The medicine is provided to Iranian patients free of charge and also exported to countries like Russia, Turkey and EU
داروی استراتژیک فاکتور ۷ آماده ورود به بازار جهانی - مشرق نیوز | آخرین اخبار ایران و جهان | mashreghnews.ir